Alcoholism: Independent predictor of survival in patients with head and neck cancer

Journal of the National Cancer Institute

Volumn 88, Issue 8, 1996, Pages 542-549

  Deleyiannis, Frederic W B ^a   Thomas, David B ^a,b   Vaughan, Thomas L ^a,b   Davis, Scott ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PROGNOSIS;

ADULT; AGED; ALCOHOLISM; CAUSE OF DEATH; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; SMOKING; SURVIVAL RATE;

EID: 0029870707     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.8.542     Document Type: Article

References (52)

1. Boyle P, Macfarlane GJ, Zheng T, Maisonneuve P, Evstifeeva T, Scully C. Recent advances in epidemiology of head and neck cancer. Curr Opin Oncol 1992;4:471-7.
2. Lowry WS. Alcoholism in cancer of the head and neck. Laryngoscope 1975;85.1275-80.
3. Hedberg K, Vaughan TL, White E, Davis S, Thomas DB. Alcoholism and cancer of the larynx: a case-control study in western Washington (United States). Cancer Causes Control 1994;5:3-8.
4. Fazekas JT, Sommer C, Kramer S. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Int J Radiat Oncol Biol Phys 1980;6:533-41.
5. Mick R, Vokes EE, Weichselbaum RR, Panje WR. Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy. Otolaryngol Head Neck Surg 1991; 105:62-73.
6. Fountzilas G. Kosmidis P, Beer M, Sridhar KS, Banis K, Vritsios A, et al. Factors influencing complete response and survival in patients with head and neck cancer treated with platinum-based induction chemotherapy. Ann Oncol 1992;3:553-8.
7. Katz AE. Immunobiological staging of patients with carcinoma of the head and neck. Laryngoscope 1983;93:445-61.
8. Katz AE. Update on immunology of head and neck cancer. Med Clin North Am 1993;77: 625-31.
9. World Health Organization. Manual of the International Classification of Diseases, Injuries, and Causes of Death. Ninth revision, 1975, Geneva: WHO, 1977.
10. National Institutes of Health, Department of Health and Human Services. Summary staging guide for the cancer surveillance, epidemiology and end results reporting (SEER) program. Bethesda (MD), 1986 (NIH Publ No. 86-2313).
11. American Joint Committee on Cancer. Manual for staging of cancer. 3rd ed. Philadelphia. Lippincott, 1988:27-44.
12. Selzer ML. The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am J Psychiatry 1971;127:1653-9.
13. Skinner HA. A multivariate evaluation of the MAST. J Stud Alcohol 1979;40:831-44.
14. Magruder-Habib K, Stevens HA, Ailing WC. Relative performance of the MAST, VAST, and CAGE versus DSM-III-R criteria for alcohol dependence. J Clin Epidemiol 1993;46:435-41.
15. Feinstein AR, Schimpff CR, Hull EW. A reappraisal of staging and therapy for patients with cancer of the rectum. I. Development of two new systems of staging. Arch Intern Med 1975;135.1441-53.
16. Wells CK, Stoller JK, Feinstein AR, Horwitz RI. Comorbid and clinical determinants of prognosis in endometrial cancer. Arch Intern Med 1984;144:2004-9.
17. Feinstein AR, Wells CK. A clinical-seventy staging system for patients with lung cancer. Medicine (Baltimore) 1990;69:1-33.
18. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR. New clinical severity staging system for cancer of the larynx. Five-year survival rates. Ann Otol Rhinol Laryngol 1994;103:83-92.
19. Hirsch RP, Riegelman RK. Statistical first aid: interpretation of health research data. Boston: Blackwell Scientific, 1992.
20. Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1989.
21. Efron B. Logistic regression, survival analysis. and the Kaplan-Meier curve. J Am Stat Assoc 1988;83:414-25
22. Norusis MJ, SPSS Inc. SPSS for Windows: advanced statistics release 6.0. Englewood Cliffs (NJ): Prentice-Hall, 1993.
23. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
24. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
25. MacGregor RR. Alcohol and immune defense. JAMA 1986;256:1474-9.
26. Liu YK. Effects of alcohol on granulocytes and lymphocytes. Semin Hematol 1980;17:130-6.
27. Berenyi MR, Straus B, Cruz D. In vitro and in vivo studies of cellular immunity in alcoholic cirrhosis. Am J Dig Dis 1974;119:199-205.
28. Saxena QB, Mezey E, Adler WH. Regulation of natural killer activity in vivo. II. The effect of alcohol consumption on peripheral blood natural killer activity. Int J Cancer 1980;26: 413-7.
29. Nair MP, Kronfol ZA, Schartz SA. Effects of alcohol and nicotine on cytotoxic functions of human lymphocytes. Clin Immunol Immunopathol 1990;54:395-409.
30. Blank SE, Duncan DA, Meadows GG. Suppression of natural killer cell activity by ethanol consumption and food restriction. Alcohol Clin Exp Res 1991;15:16-22.
31. Swerdlow MA, Chowdhury LN. IgA deposition in liver in alcoholic liver disease. An index of progressive injury. Arch Pathol Lab Med 1984;108:416-9.
32. Charpentier B, Franco D, Paci L, Charra M, Martin B, Vuitton D, et al. Deficient natural killer cell activity in alcoholic cirrhosis. Clin Exp Immunol 1984;58:107-15.
33. Ledesma F, Echevarria S. Casafont F, Lozano JL, Pons-Romero F. Natural killer cell activity in alcoholic cirrhosis: influence of nutrition. Eur J Clin Nutr 1990;44:733-40.
34. Schantz SP, Liu FJ, Taylor D, Beddingfield N, Weber RS. The relationship of circulating IgA to cellular immunity in head and neck cancer patients. Laryngoscope 1988;98:671-8.
35. Schantz SP, Shillitoe EJ, Brown BW, Campbell B. Natural killer cell activity and head and neck cancer: a clinical assessment. J Natl Cancer Inst 1986;77:869-75.
36. Mickel RA, Kessler DJ, Taylor JM, Lichtenstein A. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients. Cancer Res 1988;48:5017-22.
37. Schantz SP, Brown BW, Lira E, Taylor DL, Beddingfield N. Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunol Immunother 1987;25:141-8.
38. Schantz SP, Gocpfert H. Multimodality therapy and distant metastases: the impact of natural killer cell activity. Arch Otolaryngol Head Neck Surg 1987,113:1207-13.
39. Watzl B, Watson RR. Role of alcohol abuse in nutritional immunosuppression. J Nutr 1992; 122(3 Suppl):733-7.
40. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: McLeod CM, editor. Evaluation of chemotherapeutic agents. New York (NY): Columbia Univ Press, 1949:191-205.
41. Zubrod CG, Schneiderman M, Frei E, Brindley C, Lennard Gold G, Shnidier B, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustards and triethylene thiophosphoramide. J Chronic Dis 1960;11:7-33.
42. Feuerlein W, Kufner H, Flohrschutz T. Mortality in alcoholic patients given mpatient treatment. Addiction 1994;89:841-9.
43. Mili F, Flanders WD, Boring JR, Annest JL, DeStefano F. The associations of alcohol drinking and drinking cessation to measures of the immune system in middle-aged men. Alcohol Clin Exp Res 1992;16:688-94.
44. Barr HL, Antes D, Ottenberg DJ, Rosen A. Mortality of treated alcoholics and drug addicts: the benefits of abstinence. J Stud Alcohol 1984;45:440-52.
45. Smith EM, Cloninger CR, Bradford S Predictors of mortality in alcoholic women: a prospective follow-up study. Alcohol Clin Exp Res 1983;7:237-43.
46. Bullock KD, Reed RJ, Grant I. Reduced mortality in alcoholics who achieve long-term abstinence [published erratum appears in JAMA 1993;269:359] [see comment citation in Medline]. JAMA 1992;267:668-72.
47. Ashley MJ, Rankin JG. Hazardous alcohol consumption and diseases of the circulatory system. J Stud Alcohol 1980;41:1040-70.
48. Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM. Mont L, Rubin E. The effect of alcoholism on skeletal and cardiac muscle [see comment citation in Medline]. N Engl J Med 1989;320:409-15.
49. Gribaldo RS, Pomini GS, Sale F, Molfese G, Costa L, Maglio P, et al. Arrhythmias and left ventricular function in chronic alcoholics with alcoholic cirrhosis. Am J Cardiol 1985; 56:825-7.
50. Klatsky AL, Friedman GD, Siegelaub AB, Gerard MJ. Alcohol consumption and blood pressure Kaiser-Permanente Multiphasic Health Examination data. N Engl J Med 1977; 296:1194-200.
51. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974;27:387-404.
52. Bien TH, Miller WR, Tonigan JS. Brief interventions for alcohol problems: a review. Addiction 1993;88:315-36.